Patient characteristics and antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae infections in international travellers: a GeoSentinel analysis
Journal of Travel Medicine · 2025
DOI: 10.1093/jtm/taae090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Travel Medicine, 2025. Verfasst von Sarah L McGuinness und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Epidemiology Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Escherichia coli, Escherichia coli Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, Public Health Agency of Canada, NCEZID CDC HHS.
Abstract (Originalsprache)
Background
Antimicrobial resistance (AMR) is a global health crisis, with Enterobacterales, including Escherichia coli and Klebsiella pneumoniae, playing significant roles. While international travel to low- and middle-income countries is linked to colonization with AMR Enterobacterales, the clinical implications, particularly the risk of subsequent infection, remain unclear due to limited data. We aimed to characterize E. coli and K. pneumoniae infections in travellers and the antimicrobial susceptibility profiles of their isolates.
Methods
We analysed data on E. coli and K. pneumoniae infections in travellers collected at GeoSentinel sites between 2015 and 2022, focusing on epidemiological, clinical and microbiological characteristics. We defined multi-drug resistance (MDR) as non-susceptibility to agents from at least three drug classes.
Results
Over the 8-year period, we included 655 patients (median age 41 years; 74% female) from 57 sites in 27 countries, with 584 E. coli and 72 K. pneumoniae infections. Common travel regions included sub-Saharan Africa, Southeast Asia and South-Central Asia. Urinary tract infections predominated. Almost half (45%) were hospitalized. Among infections with antimicrobial susceptibility data across three or more drug classes, 203/544 (37%) E. coli and 19/67 (28%) K. pneumoniae demonstrated MDR. Over one-third of E. coli and K. pneumoniae isolates were non-susceptible to third-generation cephalosporins and cotrimoxazole, with 38% and 28% non-susceptible to fluoroquinolones, respectively. Travellers to South-Central Asia most frequently had isolates non-susceptible to third-generation cephalosporins, fluoroquinolones and carbapenems. We observed increasing frequencies of phenotypic extended spectrum beta-lactamase and carbapenem resistance over time.
Conclusions
E. coli and K. pneumoniae infections in travellers, particularly those to Asia, may be challenging to empirically treat. Our analysis highlights the significant health risks these infections pose to travellers and emphasizes the escalating global threat of AMR. Enhanced, systematic AMR surveillance in travellers is needed, along with prospective data on infection risk post travel-related AMR organism acquisition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Epidemiology Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Alfred Hospital, Melbourne, Victoria, Australia.
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
- Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
ORCID-Profile: Sarah L McGuinness, Maya L Nadimpalli, Michael Libman
Förderung
- NIAID NIH HHS
- Public Health Agency of Canada
- NCEZID CDC HHS
- Antibacterial Resistance Leadership Group Early Investigator Award
- National Institute of Allergy and Infectious Diseases
- NHMRC Postgraduate Scholarship
- International Society of Travel Medicine
- NHMRC Senior Research Fellowship
Zitieren
APA
McGuinness, S. L., Muhi, S., Nadimpalli, M. L., Babiker, A., Theunissen, C., Stroffolini, G., Motta, L., Gobbi, F., Huits, R., Libman, M., Leder, K., & GeoSentinel Network (2025). Patient characteristics and antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae infections in international travellers: a GeoSentinel analysis. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taae090
Vancouver
McGuinness SL, Muhi S, Nadimpalli ML, Babiker A, Theunissen C, Stroffolini G, et al. Patient characteristics and antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae infections in international travellers: a GeoSentinel analysis. Journal of Travel Medicine. 2025. doi:10.1093/jtm/taae090
BibTeX
@article{McGuinness2025,
author = {McGuinness, Sarah L and Muhi, Stephen and Nadimpalli, Maya L and Babiker, Ahmed and Theunissen, Caroline and Stroffolini, Giacomo and Motta, Leonardo and Gobbi, Federico and Huits, Ralph and Libman, Michael and Leder, Karin and GeoSentinel Network, GeoSentinel Network},
title = {Patient characteristics and antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae infections in international travellers: a GeoSentinel analysis},
journal = {Journal of Travel Medicine},
year = {2025},
doi = {10.1093/jtm/taae090}
}
EUVIMED